Related Experiment Video
Updated: Jan 11, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
Phenotypic Analysis of Pulmonary Hypertension Associated With Low Diffusion Capacity and Preserved Lung Function
Qin-Hua Zhao1, Rui Zhang1, Shao-Fei Liu1,2
1Department of Pulmonary Circulation, Shanghai Pulmonary Hospital Tongji University School of Medicine Shanghai China.
Pulmonary hypertension (PH) with low diffusion capacity of the lungs for carbon monoxide (DLCO) and preserved lung function presents two distinct phenotypes, parenchymal and vascular, both linked to poor prognosis.
Area of Science:
- Pulmonary Medicine
- Cardiology
- Radiology
Background:
- Severe diffusion impairment is noted in pulmonary arterial hypertension (PAH), especially idiopathic PAH (IPAH).
- Limited data exist on low diffusion capacity of the lungs for carbon monoxide (DLCO) with preserved lung function in broader pulmonary hypertension (PH) cohorts.
- Understanding these specific PH phenotypes is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the characteristics and outcomes of PH patients with preserved lung function and low DLCO.
- To identify distinct phenotypic patterns within this patient group using hemodynamic and CT imaging data.
Main Methods:
- Analysis of 117 PH patients with preserved lung function and low DLCO, including CT scans.
- Categorization into "Parenchymal Type" (e.g., combined pulmonary fibrosis and emphysema, interstitial lung disease) and "Vascular Type" (e.g., pulmonary veno-occlusive disease, connective tissue disease) based on features.
- Assessment of patient demographics, hemodynamic data (mean pulmonary arterial pressure), and CT findings (emphysema, fibrosis, GGO).
Main Results:
- Two main phenotypes were identified: "Parenchymal Type" (69%) and "Vascular Type" (31%).
- "Parenchymal Type" patients were older, predominantly male, with emphysema and fibrosis.
- "Vascular Type" patients were younger, predominantly female, with centrilobular GGO. Idiopathic PAH patients showed mixed characteristics.
- The overall 5-year survival rate was poor at 31%.
Conclusions:
- PH patients with low DLCO and preserved lung function exhibit distinct "Parenchymal" and "Vascular" phenotypic patterns.
- These phenotypes are associated with significant lung abnormalities and a poor prognosis.
- Further research into targeted therapies for these distinct PH phenotypes is warranted.
More Related Videos
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...